Clinical trial
Efficacy and Safety of Nicotine-Qbeta Vaccine in Smokers
NCT00369616 · Cytos Biotechnology AG, Industry · Completed
Key facts
| NCT number | NCT00369616 |
|---|---|
| Title | Efficacy and Safety of Nicotine-Qbeta Vaccine in Smokers |
| Official title | Evaluation of Efficacy and Safety of Nicotine-Qbeta (NicQb) Vaccine Versus Placebo in Healthy Smokers |
| Lead sponsor | Cytos Biotechnology AG, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Smokers |
| Intervention type | Biological |
| Interventions | CYT002-NicQb |
| Enrollment | 341 |
| Start date | Dec 1, 2003 |
| Primary completion | Mar 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Aug 29, 2006 |
| Last update posted | Nov 15, 2010 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: